Childhood tuberculosis
- PMID: 35947056
- DOI: 10.1097/QCO.0000000000000866
Childhood tuberculosis
Abstract
Purpose of review: We discuss the most recent literature to support the identification of children at risk for tuberculosis and optimal testing and treatment strategies.
Recent findings: The identification and management of children with tuberculosis has increased in complexity due to the recent severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) pandemic, greater use of immunosuppressive agents, and the administration of shorter, rifamycin-containing treatment regimens. Advancements in the diagnosis and treatment of tuberculosis in children include: use of interferon gamma release assays (IGRAs); molecular-based tests; and shorter courses of treatment. While the essential steps to identify and treat children at risk for tuberculosis remain unchanged, providers must be aware of impact of these challenges.
Summary: The SARS-CoV-2 pandemic will likely have a negative impact on global tuberculosis control. It is important that countries maintain a comprehensive approach to the identification and management of children at risk for tuberculosis. Increasing evidence supports enhanced utilization of IGRAs and molecular-based testing to improve the diagnosis of tuberculosis in children. Shorter course, rifamycin-based treatment regimens are available to treat children with tuberculosis infection; however, their use is limited in some immunosuppressed children due to drug-drug interactions.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- World Health Organization. Global tuberculosis report 2021. [Internet]. Geneva, Switzerland: World Health Organization; 2021 [updated 2021 Oct 14; cited 2022 Feb 21]. Available from: who.int/publications/i/item/9789240037021
-
- Centers for Disease Control and Prevention. Tuberculosis: Data and Statistics. [Internet]. Atlanta, Georgia, USA: Centers for Disease Control and Prevention; [updated 2022 Mar 24; cited 2022 Feb 21]. Available from: https://www.cdc.gov/tb/statistics/default.htm
-
- Deutsch-Feldman M, Pratt RH, Price SF, et al. Tuberculosis – United States, 2020. MMWR Morbid Mortal Wkly Rep 2021; 70:409–414.
-
- Bagcchi S. Dismal global tuberculosis situation due to COVID-19. Lancet Infect Dis 2021; 21:1636.
-
- Centers for Disease Control and Prevention. Tuberculosis technical instructions for civil surgeons. [Internet]. Atlanta, Georgia, USA: Centers for Disease Control and Prevention; [updated 2019 Aug 19; cited 2021 Feb 21]. Available from: cdc.gov/tb/education/technical_inst.htm
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
